Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05889221
Title Multicenter Phase 2 Study of Subcutaneous Isatuximab Plus Bortezomib, Lenalidomide and Dexamethasone in the Treatment of Newly Diagnosed Transplant Ineligible Multiple Myeloma
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Poitiers University Hospital
Indications
Therapies
Age Groups: senior
Covered Countries FRA

Facility Status City State Zip Country Details
CHU Poitiers Poitiers 86000 France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field